A U.S. judge on Monday rejected Bristol Myers Squibb's (BMY) bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former Celgene by delaying federal approval for three ...
A U.S. federal judge has allowed major portions of a $6.7 billion lawsuit against Bristol Myers Squibb to move forward, intensifying legal pressure over allegations that the pharmaceutical company ...
NEW YORK, Dec 1 (Reuters) - A U.S. judge on Monday rejected Bristol Myers Squibb's (BMY.N), opens new tab bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former Celgene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results